Sunovion Pharma and San Diego-based drug discovery platform company Afraxis have entered into a partnership agreement to use the unique enhanced spine platform (ESP), to boost Sunovion’s preclinical central nervous system (CNS) drug ...
Tags: Sunovion Pharma, Afraxis
Afraxis and PsychoGenics have formed an alliance to provide Afraxis Enhanced Spine Platform (ESP) technology as part of PsychoGenics comprehensive testing capabilities and drug discovery services. The technology can evaluate as many as ...
Tags: ESP, PsychoGenics, Afraxis